jump to navigation

Inc. Magazine Includes Dane Street on List of Fastest Growing Private Companies for 5th Consecutive Year 08/22/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

Dane Street Client Logo (M0739750xB1386)For the fifth consecutive year, MBBP client Dane Street has been included on Inc. Magazine’s exclusive List of Fastest Growing Private Companies in America. Inc. Magazine lists Dane Street’s 3-year growth as 141%. Dane Street provides Independent Medical Examination and Peer Review services to the auto, disability, group health, pharmacy, and workers’ compensation industries.

Congratulations to our client on this well-deserved recognition.

Lisa McKerracher of BioAxone BioSciences Joins Advisory Panel for Christopher Reeve Foundation 08/10/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , , ,
add a comment

Lisa McKerracher, CEO of MBBP client BioAxone BioSciences, has accepted the role of Consortium Advisory Panelist for the Christopher & Dana Reeve Foundation. Dr. McKerracher will “direct the foundation’s focus toward the identification, development, and translation of potential Spinal Cord Injury (SCI) therapies into the clinic.”

BioAxone BioSciences is a clinical-state biopharmaceutical company developing regenerative therapeutic drugs based on a deep understanding of axon regeneration and neuronal signaling pathways. The Christopher & Dana Reeve Foundation is dedicated to advancing quality of life and discovering cures for spinal cord injury.

More information can be found in the full release.

David Sabatini To Be Awarded 2017 Dickson Prize in Medicine 08/10/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , , ,
add a comment

whitehead-institute-client-logo-sm-m0055040xb1386Biologist David Sabatini of MBBP client Whitehead Institute will receive the University of Pittsburgh’s 2017 Dickson Prize in Medicine. The Dickson Prize in Medicine is awarded annually to a leading American investigator who is engaged in innovative, paradigm-shifting biomedical research.

Sabatini discovered mTOR, a key cellular regulatory metabolic pathway. In addition to being a member of the Whitehead Institute for Biomedical Research, he teaches biology at MIT and is a senior associate at the Broad Institute of MIT and Harvard University. He is also a member of the MIT Koch Institute for Integrative Cancer Research and is a Howard Hughes Medical Institute investigator.

The award will be presented to Sabatini in October at the University of Pittsburgh’s Science 2017 event. More information can be found on the University’s Dickson Prize in Medicine page.

Bach Pharma’s GVT Drug Reverses Brain Dysfunction, Report Shows 08/09/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , , , ,
add a comment

Firm client Bach Pharma’s GVT drug successfully reverses brain dysfunction and therefore may be an effective treatment for victims of Gulf War Illness (GWI), according to a Department of Defense report on the results of a multi-year pre-clinical study conducted by Ashok K. Shetty, PhD, Associate Director and Professor at the Institute for Regenerative Medicine at the College of Medicine at Texas A&M University System. GWI is prevalent among servicemen and women from the Gulf War and can cause memory impairment, depression, and anxiety. The study was conducted under a grant from the DoD.

GVT has proven both neuro-protective and neuro-generative and could potentially act as a therapeutic treatment for chemical poisoning associated disorders. The fact that GVT regenerates stem cells and neurons was an unexpected finding of this study. Based on these results, Dr. Shetty has established a collaboration with Dena Davidson, PhD, deputy director of research at the Veterans Integrated Service Network (VISN) 17 Center of Excellence for Research on Returning War Veterans to pursue clinical trials in GWI patients.

Congratulations to our client, Bach Pharma, on this extraordinary achievement. Read the full press release for more information.

NIH/SBIR Grant Awarded to Firm Client BioAxone BioSciences for BA-1049 Inhibitor Research 08/03/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

The National Institutes of Health (NIH), Small Business Innovation Research (SBIR), and National Institute of Neurological Disorders and Stroke have awarded firm client BioAxone BioSciences, Inc. with a $1.5 million grant. The grant is for continued research for BioAxone’s Rho Kinase 2 (ROCK2) inhibitor, BA-1049, a transformative drug to treat cerebral cavernous malformation, a serious genetic disease.

BioAxone is a clinical-state biopharmaceutical company developing regenerative therapeutic drugs based on a deep understanding of axon regeneration and neuronal signaling pathways.

Congratulations to our client on receiving the grant and on their revolutionary drug research. For more information, read the full release.

Firm Clients Sheprd and iZotope Are Finalists in MassTLC Leadership Awards 07/27/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Computer Software & Hardware, Internet and E-Commerce, Telecommunications & Networking.
Tags: , , ,
add a comment

Firm clients Sheprd and iZotope are among the 2017 MassTLC Technology Leadership Awards finalists. The awards, presented by the Mass Technology Leadership Council, are comprised of individual and company categories, including CEO of the Year, Emerging Executive of the Year, Emerging Company of the Year, Cutting Edge Technology of the Year, and Technology for a Better Tomorrow, among others.

Sheprd and iZotope are both finalists in the Innovative Tech of the Year: Consumer category. The winners will be announced at the MassTLC Leadership Awards Gala on September 14th.

Congratulations and good luck to our clients, Sheprd and iZotope.

BioAxone BioSciences Peer-Reviewed Research Article Published in Frontiers Journal Series 07/20/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

Firm client BioAxone BioSciences announced that its peer-reviewed research article on axon regeneration was published in Frontiers Journal Series, Frontiers in Molecular Neuroscience. The article “MAG, Myelin and Overcoming Growth Inhibition in the CNS” was written by BioAxone’s CEO Lisa McKerracher, Ph.D. and Kenneth Rosen, Ph.D., VP of Research. Frontiers in Molecular Neuroscience publishes rigorously peer-reviewed research that aims to identify key molecules underlying the structure, design, and function of the brain across all levels.

BioAxone is a clinical-state biopharmaceutical company developing regenerative therapeutic drugs based on a deep understanding of axon regeneration and neuronal signaling pathways.

Congratulations to our client on this achievement. For more information, read the press release.

ConforMIS Receives FDA Clearance for iTotal Hip Replacement System 06/27/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences, Medical Devices.
Tags: ,
add a comment

conformis-inc-logoFirm client ConforMIS, Inc. received FDA 510(k) clearance for its primary iTotal Hip replacement system. Chief Executive Officer and President Mark Augusti remarked:

Having treated over 50,000 patients with customized knee replacement implants, ConforMIS brings over a decade of experience in patient-specific technology to the hip replacement market. FDA clearance of iTotal Hip demonstrates the ability to apply our proprietary iFit® image-to-implant technology to other joints. There has been a trend towards personalized healthcare and we believe patients expect and deserve personalized treatment.”

The iTotal Hip replacement system has technology that is similar to that used in ConforMIS’s customized knee implants. The company hopes to improve patient outcomes through customized implants for joint replacements.

Congratulations to our client on this achievement. For more information, read the full announcement.

iSpecimen Unveils Online Biospecimen Marketplace 06/13/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

iSpecimen Logo (M0910032xB1386)Firm client iSpecimen has launched an online biospecimen marketplace for the life sciences industry. The company hopes that the marketplace will alleviate scientists’ difficulty in finding high-quality samples of human material necessary to conduct research.

The marketplace compiles available samples and allows users to search by patient information. Users can then order the corresponding materials.

For more information about the iSpecimen Marketplace, read the full article in the BBJ, or iSpecimen’s press release.

MBBP Clients Included in MassChallenge 2017 Startup Class 05/25/2017

Posted by Morse Barnes-Brown Pendleton in Client News.
Tags: , , , ,
add a comment

logo_mcFirm clients DropZone for Veterans and Skelmet are among the 128 startups that will be a part of this year’s MassChallenge Boston accelerator program. MassChallenge helps the world’s highest-impact and highest-potential startups launch, grow, and make an impact across various industries. The program received more than 1,500 applications this year, and will end with the MassChallenge Boston Awards, where startups will compete for shares of more than $1.5 million in equity-free awards.

DropZone for Veterans is a customizable directory of high-impact veteran benefits including education, employment, family, and health and wellness. Skelmet is revolutionizing the eyewear industry with 3D Fit technology, combining state of the art 3D scanning with 3D printing to automatically measure, design, and produce bespoke sunglasses.

Congratulations to DropZone for Veterans and Skelmet!

Applied BioMath and Northern Biologics to Collaborate on Biotherapeutic Candidate in Oncology 04/21/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

Applied BioMath logo (M1064209xB1386)Firm client Applied BioMath, the industry-leader in applying mechanistic modeling to drug research and development, announced a collaboration with Northern Biologics, an innovative antibody discovery and development company. The companies will focus on traditional and mechanistic pharmacokinetic and pharmacodynamics (PK/PD) modeling for a biotherapeutic candidate in oncology. Applied BioMath will leverage both traditional PK/PD models and semi-mechanistic PK/PD models, while Northern Biologics will use this model to strengthen their understanding of the parameters that will determine optimal dosing paradigms.

Congratulations to our client on this new collaboration. For more information, read the full press release.

WatchRx Selected as Top Innovator by AARP and MedCity News 04/19/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Medical Devices, Telecommunications & Networking.
Tags: , , ,
add a comment

WatchRx Logo (M0897830xB1386)Jayanthi Narasimhan, Founder and CEO of firm client WatchRx, has been named a 50+ Innovation Leader by AARP and MedCity News. The honor recognizes the leading innovators of services and products designed to serve the booming 50+ consumer health market.

Those who made the list were selected by their peers by voting. Modernizing patient care to meet the needs of today’s mobile world was a common goal of many of the winners, as well as exceptional creativity in alternative therapies, smart wearables, and product design.

WatchRx was founded from the need of the founders’ to assist their aging parents with managing medications and health conditions remotely for their multiple chronic conditions. The company delivers global award winning products to consumer, telecommunications, and enterprise industries.

Congratulations to all of the winners and to our client, Jayanthi of WatchRx!

Visible Good Advances to Finals in SBANE Innovation Awards 04/12/2017

Posted by Morse Barnes-Brown Pendleton in Client News.
Tags: , ,
add a comment

Visible Good Logo (M0692054xB1386)Visible Good, a firm client, has been selected as a finalist in this year’s SBANE New England Innovation Awards. The Innovation Awards recognize companies that have transformed their innovative ideas into a product or service that delivers proven value to customers. This year’s competition began with 200 companies, and has since been narrowed to twenty.

Visible Good provides shelter to those in need, specifically for humanitarian assistance and disaster relief. We are proud to have them as a client and congratulate them on their place as a finalist!

MBBP Corporate Attorneys Represent Mosse & Mosse Associates in Acquisition of Certain Assets by Risk Strategies Company 04/12/2017

Posted by Morse Barnes-Brown Pendleton in Attorney News, Client News, Corporate, Deal News, MBBP news.
Tags: , ,
add a comment

A team of Morse Barnes Brown Pendleton attorneys, led by Joe Marrow, Dave Czarnecki, Kelly Hinkel and corporate paralegal Yongha Lee, recently represented our client Mosse & Mosse Associates, LLC in a sale of certain assets to Risk Strategies Company. Mosse & Mosse provides its client base with both employee benefits and retirement plan consulting services. Risk Strategies Company, a privately-held, rapidly-growing national insurance brokerage and risk management firm, has expanded its employee benefits practice and expertise through the Mosse & Mosse acquisition. The sale of assets did not include Mosse & Mosse’s benefits business related to municipalities and educational institutions, and MBBP will continue to represent Mosse & Mosse in that on-going enterprise.

Dane Street Selected for Boston Business Journal’s 2017 FAST 50 List 04/05/2017

Posted by Morse Barnes-Brown Pendleton in Client News.
add a comment

Dane Street Client Logo (M0739750xB1386)Firm client Dane Street has been named, for the fourth consecutive year, to Boston Business Journal’s (BBJ) 2017 FAST 50 List of Top Fastest Growing Private Companies in Massachusetts. Dane Street provides Independent Medical Examination and Peer Review services to the auto, disability, group health, pharmacy, and workers’ compensation industries.

BBJ’s publisher, Carolyn M. Jones, said “these companies represent the best examples of the Boston economy’s strength and vibrancy”. Companies are included on the list based on revenue growth over the prior three years.

Congratulations to our client! For more information, read the full article.

Boston University Senior Business Lecturer Greg Stoller Shares Top Four Asian Business Trends 03/22/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Corporate.
Tags: , , ,
add a comment

Greg Stoller, a friend of the firm and a senior lecturer at BU’s Questrom School of Business, recently returned from a visit to Asia, which included visits to 10 firms in Shanghai and Hong Kong. Among the insights he gained:

Many of the firms are ditching long-term strategic planning in favor of speed and agility, in order to obtain short-term profits and keep competitors at bay.”

In his article “Four Asian Business Trends Happening in Real Time” Greg shares the top 4 trends he experienced in the way business is conducted in China and its neighbors.

MBBP Client Atrex Receives Canadian Standards Association Approval for Remote Power Generators 03/02/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Manufacturing, Retail & Service.
Tags: , , , , , , , ,
add a comment

Firm client Atrex Energy, Inc. received approval from a Canadian standards group for its remote power generators, which are used in applications for the oil and gas industry. This is the first-ever certification from the Canadian Standards Association (CSA) under its new FC-1 Standard for its high efficiency and fuel flexible ARP units. CSA certification is a rigorous standard of safety, and as such recognizes the safety and reliability of the technology in Atrix’s remote power generators. Many customers require equipment to have the certification, making this a major achievement for Atrex.

Atrex is based in Walpole, MA and its products offer low carbon, environmental solutions for essential off-grid power needs. To read more about the certification and Atrex’s remote power generators, read the full article featured in the latest edition of North American Oil & Gas Pipelines.

MBBP Trademark Client FusionStorm Earns Ultra-Exclusive Dell EMC Titanium Black Honor 02/01/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Computer Software & Hardware.
Tags: , , , , , , , , , , ,
add a comment

MBBP’s trademark client FusionStorm has truly earned its stripes over the past six years fusionstorm-logoafter receiving more than a dozen Partner of the Year vendor awards, and recently having been handpicked as one of the partners to join the extremely exclusive Dell EMC Titanium Black program. This program gives FusionStorm access to a broad range of exclusive benefits aimed at driving sales growth, and also provides the company with the ability to meet, confer, and brief with Dell’s top technologists and Dell EMC CEO Michael Dell. FusionStorm’s CEO of five years, Dan Serpico, has attributed the company’s success to its ability to adapt to how the environment and market each shift, to maintain the company’s strong relationships with vendors and customers, and to lead the company through shifts in the industry.

The company’s entrepreneurial sales approach and technical expertise have served to build the company’s culture, and in turn, its ability to deliver its service product. Serpico attributes the company’s great success to FusionStorm’s employees and their innovative ideas, as listening and paying attention to the workers is another segment of FusionStorm’s culture. The company works incredibly hard to remain ahead of competitors in order to predict shifts and remain relevant within the industry. With the company’s recent and incredible success, Serpico emphasizes the importance of continuous innovation, and the company pays very close attention to the future of the industry, and how FusionStorm will remain a part of it. Congratulations to FusionStorm!

For more information, read the full article.

Revised HSR Thresholds 2017 01/27/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Corporate, M&A.
Tags: , , , , , , , , , ,
add a comment

On January 19, 2017, the Federal Trade Commission (FTC) issued its annual press release announcing revised jurisdictional thresholds for 2017 in connection with reportable jmc-headshot-photo-2015-m0846508xb1386transactions under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). These new HSR thresholds will go into effect 30 days after they are published in the Federal Register, which is expected to happen in late February.

For more information about the revised thresholds, read the full post written by corporate attorney Jonathan M. Calla on our M&A Today blog.

MBBP Trademark Client Visible Measures On How to Launch a Super Bowl Campaign 01/27/2017

Posted by Morse Barnes-Brown Pendleton in Client News.
add a comment

With Super Bowl LI only a week and change away, it is important for brands and new-logo-as-of-2015-01-08-vmclogo_260x80-2advertisers to know how to connect with their audiences by creating a powerful and impressionable advertising campaign. MBBP’s trademark client Visible Measures, the leader in social video attention measurement and activation, has this down to a science with their Super Bowl Attention Playbook. The Super Bowl grosses one of the highest viewer ratings in the country all year, with more than 110 million viewers in the United States alone; therefore, it is of the utmost importance that brands and advertisers are aware of the best ways to create a hit campaign, and Visible Measures provides the Golden Ticket.

Visible Measures examined previous advertising trends surrounding past Super Bowls, and has created an advertising “playbook” on the key techniques to create a successful campaign. This includes: going beyond Facebook to Youtube, where 3x as much viewing occurs; knowing the prime times during the game to execute a campaign for maximum views; and more. Visible Measures is a company fueled by data that has successfully assisted many advertisers and brands in their endeavor to spread their message, and we can’t wait to see what they have in store for us on February 5th. Go Visible Measures and go Patriots!

For more information, check out the full article.

%d bloggers like this: